Health
FDA approves clinical trials to test the safety of cancer-detection technology – News-Medical.Net
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University:…
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.
The molecular-targeted imaging agent is licensed to Molecular Theranostics LLC, a Cleveland based startup company, and its partners U.S. Motek LLC and Jiangsu Motek Pharmaceuticals Ltd. of China.
The agent…
-
Noosa News22 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General11 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
General15 hours agoCoalition to chart path forward as family feud cooled
-
General23 hours agoDavid Littleproud’s own goal • Inside Story